TMO:NYE-Thermo Fisher Scientific Inc (USD)

EQUITY | Diagnostics & Research | New York Stock Exchange

Last Closing

USD 590.12

Change

-3.89 (-0.65)%

Market Cap

USD 56.05B

Volume

1.13M

Analyst Target

USD 451.22
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Thermo Fisher Scientific Inc offers analytical instruments, laboratory equipment, software, services, consumables, reagents, chemicals, and supplies to pharmaceutical and biotech companies, hospitals and clinical diagnostic labs.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-21 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
DHR Danaher Corporation

-0.16 (-0.06%)

USD 190.21B
IQV IQVIA Holdings Inc

-1.21 (-0.57%)

USD 39.94B
A Agilent Technologies Inc

-0.72 (-0.55%)

USD 37.89B
MTD Mettler-Toledo International I..

-19.70 (-1.34%)

USD 30.86B
WAT Waters Corporation

-0.57 (-0.19%)

USD 17.83B
LH Laboratory Corporation of Amer..

+3.40 (+1.73%)

USD 16.43B
DGX Quest Diagnostics Incorporated

-0.68 (-0.49%)

USD 15.68B
RVTY Revvity Inc.

-2.07 (-1.87%)

USD 13.69B
CRL Charles River Laboratories

-2.97 (-1.40%)

USD 10.74B
QGEN Qiagen NV

-1.01 (-2.33%)

USD 9.95B

ETFs Containing TMO

XDNA 9.55 % 0.00 %

N/A

N/A
SYNB Putnam Biorevolution ETF 7.84 % 0.00 %

-0.12 (0.75%)

USD 5.43M
FHI:CA CI Health Care Giants Cov.. 5.13 % 0.75 %

-0.14 (0.75%)

CAD 0.09B
LIFE-B:CA Evolve Global Healthcare .. 4.99 % 0.00 %

-0.08 (0.75%)

CAD 0.01B
BGU:CA Bristol Gate Concentrated.. 4.74 % 0.85 %

-0.07 (0.75%)

CAD 0.11B
XGEN:XETRA Xtrackers MSCI Genomic He.. 4.69 % 0.00 %

-0.16 (0.75%)

USD 3.46M
XGES:LSE Xtrackers MSCI Genomic He.. 4.69 % 0.00 %

-0.09 (0.75%)

USD 3.46M
AILG 4.51 % 0.00 %

N/A

N/A
SXLV:SW SPDR S&P U.S. Health Care.. 4.22 % 0.00 %

N/A

N/A
GXLV:LSE SPDR® S&P® U.S. Health .. 4.14 % 0.00 %

+0.31 (+0.75%)

USD 0.39B
IUHC:SW iShares S&P 500 Health Ca.. 4.12 % 0.00 %

N/A

USD 2.24B
IUHC:LSE iShares S&P 500 USD Healt.. 4.11 % 0.00 %

+0.04 (+0.75%)

USD 2.24B
XUHC:SW Xtrackers MSCI USA Health.. 4.10 % 0.00 %

N/A

USD 0.79B
MHCD:CA Middlefield Healthcare Di.. 4.09 % 0.00 %

-0.03 (0.75%)

CAD 0.16B
WH2E:XETRA Invesco Markets II plc - .. 3.83 % 0.00 %

+0.06 (+0.75%)

USD 2.36M
PINK Simplify Exchange Traded .. 3.69 % 0.00 %

-0.09 (0.75%)

USD 0.12B
DRUG:AU BetaShares Global Healthc.. 3.58 % 0.00 %

N/A

USD 0.17B
CDNA:CA CI Bio-Revolution ETF 3.34 % 0.00 %

N/A

CAD 5.88M
CURE Direxion Daily Healthcare.. 3.04 % 1.06 %

-0.16 (0.75%)

USD 0.19B
XWHS:LSE Xtrackers MSCI World Heal.. 2.93 % 0.00 %

+0.32 (+0.75%)

USD 2.51B
WHEA:SW SPDR MSCI World Health Ca.. 2.93 % 0.00 %

-0.20 (0.75%)

N/A
IXJ iShares Global Healthcare.. 2.92 % 0.46 %

-0.22 (0.75%)

USD 4.02B
HEAW:LSE SPDR® MSCI World Health .. 2.85 % 0.00 %

+0.36 (+0.75%)

USD 0.58B
ABIE:XETRA AXA IM ACT Biodiversity E.. 2.62 % 0.00 %

-0.04 (0.75%)

N/A
MOAT:SW VanEck Morningstar US Sus.. 2.60 % 0.00 %

-0.18 (0.75%)

N/A
ABIT:F AXA IM ACT Biodiversity E.. 2.42 % 0.00 %

+0.04 (+0.75%)

N/A
ABIE:F AXA IM ACT Biodiversity E.. 2.42 % 0.00 %

-0.08 (0.75%)

N/A
LRGE ClearBridge Large Cap Gro.. 2.35 % 0.59 %

+0.20 (+0.75%)

USD 0.24B
ABIT:XETRA AXA IM ACT Biodiversity E.. 2.28 % 0.00 %

+0.03 (+0.75%)

USD 0.41B
HYLG Global X Funds - Global X.. 1.94 % 0.00 %

-0.03 (0.75%)

USD 2.85M
PSET Principal Quality ETF 1.52 % 0.29 %

-0.36 (0.75%)

USD 0.05B
DFUV Dimensional US Marketwide.. 1.20 % 0.00 %

-0.31 (0.75%)

USD 10.43B
JPST JPMorgan Ultra-Short Inco.. 0.74 % 0.00 %

+0.01 (+0.75%)

USD 23.40B
CWS AdvisorShares Focused Equ.. 0.00 % 0.68 %

-0.13 (0.75%)

USD 0.15B
FHLC Fidelity® MSCI Health Ca.. 0.00 % 0.08 %

-0.12 (0.75%)

USD 3.03B
IBLN 0.00 % 0.64 %

N/A

N/A
IYH iShares U.S. Healthcare E.. 0.00 % 0.43 %

-0.03 (0.75%)

USD 3.35B
JHMH 0.00 % 0.46 %

N/A

N/A
LDUR PIMCO Enhanced Low Durati.. 0.00 % 1.02 %

-0.05 (0.75%)

USD 0.88B
JMIN 0.00 % 0.12 %

N/A

N/A
ACT Enact Holdings Inc 0.00 % 0.75 %

-0.17 (0.75%)

USD 4.69B
KORP American Century Diversif.. 0.00 % 0.45 %

+0.01 (+0.75%)

USD 0.25B
LS:CA Middlefield Healthcare & .. 0.00 % 2.21 %

N/A

CAD 0.16B
HWF:CA 0.00 % 0.00 %

N/A

N/A
CGAA:CA CI Global Asset Allocatio.. 0.00 % 0.00 %

N/A

CAD 0.02B
FHI-B:CA CI Health Care Giants Cov.. 0.00 % 0.00 %

-0.05 (0.75%)

CAD 0.05B
RXD ProShares UltraShort Heal.. 0.00 % 0.77 %

+0.07 (+0.75%)

USD 0.85M
RXD ProShares UltraShort Heal.. 0.00 % 0.95 %

+0.07 (+0.75%)

USD 0.85M
RXL ProShares Ultra Health Ca.. 0.00 % 0.95 %

-0.48 (0.75%)

USD 0.09B
VHT Vanguard Health Care Inde.. 0.00 % 0.10 %

-0.39 (0.75%)

USD 17.71B
XHC:CA iShares Global Healthcare.. 0.00 % 0.65 %

-0.18 (0.75%)

CAD 0.60B
XLV Health Care Select Sector.. 0.00 % 0.13 %

-0.05 (0.75%)

USD 39.31B
LIFE:CA Evolve Global Healthcare .. 0.00 % 0.69 %

N/A

CAD 0.01B
IHCU:LSE iShares S&P 500 Health Ca.. 0.00 % 0.00 %

+7.75 (+0.75%)

USD 1.69B
MOAT:LSE VanEck Morningstar US Sus.. 0.00 % 0.00 %

-0.20 (0.75%)

USD 0.45B
SXLV:LSE SPDR S&P U.S. Health Care.. 0.00 % 0.00 %

+0.14 (+0.75%)

USD 0.39B
WHEA:LSE SPDR® MSCI World Health .. 0.00 % 0.00 %

+0.12 (+0.75%)

USD 0.59B
XDWH:LSE Xtrackers MSCI World Heal.. 0.00 % 0.00 %

+0.07 (+0.75%)

USD 2.59B
XFVT:LSE Xtrackers FTSE Vietnam Sw.. 0.00 % 0.00 %

-9.25 (0.75%)

USD 0.35B
XSHC:LSE Xtrackers MSCI USA Health.. 0.00 % 0.00 %

+38.75 (+0.75%)

USD 0.79B
XUHC:LSE Xtrackers MSCI USA Health.. 0.00 % 0.00 %

+0.17 (+0.75%)

USD 0.79B
XVTD:LSE Xtrackers - FTSE Vietnam .. 0.00 % 0.00 %

-0.32 (0.75%)

USD 0.31B
QDVG:F iShares S&P 500 Health Ca.. 0.00 % 0.00 %

+0.06 (+0.75%)

USD 2.09B
XDWH:F Xtrackers (IE) Public Lim.. 0.00 % 0.00 %

+0.10 (+0.75%)

USD 2.60B
XUHC:F Xtrackers (IE) Public Lim.. 0.00 % 0.00 %

+0.27 (+0.75%)

USD 0.85B
ZPDH:F SPDR S&P U.S. Health Care.. 0.00 % 0.00 %

+0.25 (+0.75%)

USD 0.40B
DXSI:XETRA Xtrackers - Stoxx Europe .. 0.00 % 0.00 %

-1.26 (0.75%)

USD 0.02B
GMVM:XETRA VanEck Morningstar US Sus.. 0.00 % 0.00 %

+0.17 (+0.75%)

USD 0.53B
QDVG:XETRA iShares S&P 500 Health Ca.. 0.00 % 0.00 %

+0.09 (+0.75%)

USD 2.05B
XDWH:XETRA Xtrackers MSCI World Heal.. 0.00 % 0.00 %

+0.38 (+0.75%)

USD 2.60B
XUHC:XETRA Xtrackers MSCI USA Health.. 0.00 % 0.00 %

+0.46 (+0.75%)

USD 0.85B
ZPDH:XETRA SPDR S&P U.S. Health Care.. 0.00 % 0.00 %

+0.36 (+0.75%)

USD 0.40B
HIG-U:CA 0.00 % 0.00 %

N/A

N/A
ZGEN:CA 0.00 % 0.00 %

N/A

N/A
XMLH:XETRA L&G Healthcare Breakthrou.. 0.00 % 0.00 %

-0.06 (0.75%)

USD 0.07B
OUFH:XETRA 0.00 % 0.00 %

N/A

N/A
IXJ:AU iShares Global Healthcare.. 0.00 % 0.00 %

+0.24 (+0.75%)

USD 1.35B
DWEQ 0.00 % 0.00 %

N/A

N/A
BGU-U:CA Bristol Gate Concentrated.. 0.00 % 0.00 %

-0.14 (0.75%)

CAD 0.11B
MOGB:LSE VanEck Morningstar US Sus.. 0.00 % 0.00 %

+0.16 (+0.75%)

USD 0.45B
TDOC:CA TD Global Healthcare Lead.. 0.00 % 0.00 %

-0.06 (0.75%)

CAD 0.08B
PFUT Putnam Sustainable Future.. 0.00 % 0.00 %

-0.08 (0.75%)

USD 0.26B
SROI Calamos Antetokounmpo Glo.. 0.00 % 0.00 %

-0.17 (0.75%)

USD 0.01B

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.18% 85% B 75% C
Dividend Return 0.07% 14% F 2% F
Total Return 11.25% 85% B 73% C
Trailing 12 Months  
Capital Gain 12.38% 69% C- 55% F
Dividend Return 0.14% 17% F 1% F
Total Return 12.52% 69% C- 47% F
Trailing 5 Years  
Capital Gain 117.74% 91% A- 87% B+
Dividend Return 1.76% 20% F 5% F
Total Return 119.50% 91% A- 86% B+
Average Annual (5 Year Horizon)  
Capital Gain 17.36% 92% A 82% B
Dividend Return 17.58% 85% B 80% B-
Total Return 0.22% 33% F 5% F
Risk Return Profile  
Volatility (Standard Deviation) 23.27% 69% C- 48% F
Risk Adjusted Return 75.58% 100% F 92% A
Market Capitalization 56.05B 100% F 99% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Diagnostics & Research) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 38.16 50% 17%
Price/Book Ratio 4.62 46% 19%
Price / Cash Flow Ratio 27.03 38% 11%
Price/Free Cash Flow Ratio 21.90 31% 12%
Management Effectiveness  
Return on Equity 13.62% 62% 69%
Return on Invested Capital 8.92% 57% 61%
Return on Assets 4.82% 54% 71%
Debt to Equity Ratio 67.01% 38% 50%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.